RYBELSUS 7 MG COM OR CT BL AL AL X 60
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1176600370072 -
GGREM
526620120008807 -
Código de barras
7897705202722
O que a fonte publica
- Detentor do registro
- NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA
- Princípios ativos
- SEMAGLUTIDA
- Embalagem
- 7 MG COM OR CT BL AL AL X 60
- Tipo de produto
- Biológico
- Classe terapêutica
- A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "RYBELSUS 7 MG COM OR CT BL AL AL X 60",
"holder": "NOVO NORDISK FARMACÊUTICA DO BRASIL LTDA",
"stripe": null,
"barcodes": [
"7897705202722"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526620120008807",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "82.277.955/0001-55",
"priceRegime": "Regulado",
"productName": "RYBELSUS",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "7 MG COM OR CT BL AL AL X 60",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "1721.68",
"icms-12": "1956.46",
"icms-17": "2074.31",
"icms-18": "2099.61",
"icms-19": "2125.53",
"icms-20": "2152.10",
"icms-21": "2179.34",
"icms-22": "2207.28",
"icms-23": "2235.95",
"icms-17.5": "2086.88",
"icms-19.5": "2138.73",
"icms-20.5": "2165.64",
"icms-22.5": "2221.52",
"icms-12-alc": "1746.84",
"icms-17-alc": "1852.06",
"icms-18-alc": "1874.65",
"icms-19-alc": "1897.79",
"icms-20-alc": "1921.52",
"icms-21-alc": "1945.84",
"icms-22-alc": "1970.79",
"icms-23-alc": "1996.38",
"withoutTaxes": "1537.21",
"icms-17.5-alc": "1863.29",
"icms-19.5-alc": "1909.58",
"icms-20.5-alc": "1933.60",
"icms-22.5-alc": "1983.50"
},
"pisCofinsList": "Negativa",
"substanceText": "SEMAGLUTIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "2309.57",
"icms-12": "2624.52",
"icms-17": "2782.61",
"icms-18": "2816.55",
"icms-19": "2851.32",
"icms-20": "2886.97",
"icms-21": "2923.51",
"icms-22": "2960.99",
"icms-23": "2999.45",
"icms-17.5": "2799.48",
"icms-19.5": "2869.03",
"icms-20.5": "2905.13",
"icms-22.5": "2980.09",
"icms-12-alc": "2414.90",
"icms-17-alc": "2560.36",
"icms-18-alc": "2591.59",
"icms-19-alc": "2623.58",
"icms-20-alc": "2656.39",
"icms-21-alc": "2690.01",
"icms-22-alc": "2724.50",
"icms-23-alc": "2759.88",
"withoutTaxes": "2125.11",
"icms-17.5-alc": "2575.89",
"icms-19.5-alc": "2639.88",
"icms-20.5-alc": "2673.09",
"icms-22.5-alc": "2742.07"
},
"invalidBarcodes": [],
"activeSubstances": [
"SEMAGLUTIDA"
],
"therapeuticClass": "A10S - ANTIDIABÉTICOS AGONISTAS DE GLP-1",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1176600370072",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "A10S",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526620120008807"